A multicenter analysis of lung transplantation outcomes comparing donation after circulatory death and donation after brain death

Donor organ shortage is a barrier to lung transplantation. Donation after circulatory death (DCD) may offer a solution, although it is underutilized. The objective of this study was to compare survival and other postoperative outcomes between DCD and donation after brain death (DBD). We performed a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JHLT open 2024-11, Vol.6, p.100132, Article 100132
Hauptverfasser: Abul Kashem, Mohammed, Loor, Gabriel, Hartwig, Matthew, Van Raemdonck, Dirk, Villavicencio, Mauricio, Ius, Fabio, Ghadimi, Kamrouz, Salman, Jawad, Chandrashekaran, Satish, Machuca, Tiago, Sanchez, Pablo G., Subramaniam, Kathirvel, Neyrinck, Arne, Calvelli, Hannah, Warnick, Michael, Zhao, Huaqing, Huddleston, Stephen, Osho, Asishana, D'Silva, Ethan, Ramamurthy, Uma, Pena, Andres Leon, Salan-Gomez, Marcelo, Shaffer, Andrew, Langer, Nathaniel, Emtiazjoo, Amir, Toyoda, Yoshiya
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Donor organ shortage is a barrier to lung transplantation. Donation after circulatory death (DCD) may offer a solution, although it is underutilized. The objective of this study was to compare survival and other postoperative outcomes between DCD and donation after brain death (DBD). We performed a multicenter analysis of Multi-Institutional Extracorporeal Life Support (ECLS) Registry data from 11 lung transplant centers in the United States and Europe. Demographics and clinical parameters were compared using chi-square test and Fisher's exact test. Survival was assessed by Kaplan-Meier curves and compared by log-rank test with propensity score matching. Of 1,585 patients included in the study, 135 (8.5%) received DCD lungs and 1,450 (91.5%) received DBD lungs. DCD recipients had higher rates of obstructive lung disease (p = 0.042), longer total ischemic time (p 
ISSN:2950-1334
2950-1334
DOI:10.1016/j.jhlto.2024.100132